Evidence map›Paper›PMID 33563311›Full record

ArticleCritical care (London, England)2021

Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation.

Romain Chopard, David Jimenez, Guillaume Serzian, Fiona Ecarnot, Nicolas Falvo, Elsa Kalbacher, Benjamin Bonnet, Gilles Capellier, François Schiele, Laurent Bertoletti and 2 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. The Predictive Value of the MELD Scores for In-Hospital Adverse Events in Normotensive Patients with Acute Pulmonary Embolism.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Romain ChopardDepartment of Cardiology, University Hospital Jean Minjoz, 3 Boulevard Fleming, 25000, Besançon, France. chopardromain@yahoo.fr.ORCID 0000-0002-8358-515X
David JimenezRespiratory Department, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Guillaume SerzianDepartment of Cardiology, University Hospital Jean Minjoz, 3 Boulevard Fleming, 25000, Besançon, France.
Fiona EcarnotDepartment of Cardiology, University Hospital Jean Minjoz, 3 Boulevard Fleming, 25000, Besançon, France.
Nicolas FalvoDepartment of Internal Medicine, University Hospital Dijon-Bourgogne, Dijon, France.
Elsa KalbacherMedical Oncology Unit, University Hospital Besançon, Besançon, France.
Benjamin BonnetDepartment of Cardiology, General Hospital, Vesoul, France.
Gilles CapellierEA3920, University of Burgundy Franche-Comté, Besançon, France.
François SchieleDepartment of Cardiology, University Hospital Jean Minjoz, 3 Boulevard Fleming, 25000, Besançon, France.
Laurent BertolettiDepartment of Vascular and Therapeutic Medicine, Saint-Etienne University Hospital, Saint-Etienne, France.
Manuel MonrealDepartment of Internal Medicine, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
Nicolas MeneveauDepartment of Cardiology, University Hospital Jean Minjoz, 3 Boulevard Fleming, 25000, Besançon, France.
Université de Bourgogne · FRCentre Hospitalier Universitaire de Besançon · FRHospital Universitari Germans Trias i Pujol · ESInserm · FRMaison des Sciences sociales et des Humanités de Dijon · FRSaint-Gobain (France) · FRUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal dysfunction influences outcomes after pulmonary embolism (PE). We aimed to determine the incremental value of adding renal dysfunction, defined by estimated glomerular filtration rate (eGFR), on top of the European Society of Cardiology (ESC) prognostic model, for the prediction of 30-day mortality in acute PE patients, which in turn could lead to the optimization of acute PE management.

methodsWe performed a multicenter, non-interventional retrospective post hoc analysis based on a prospectively collected cohort including consecutive confirmed acute PE stratified per ESC guidelines. We first identified which of three eGFR formulae most accurately predicted death. Changes in global model fit, discrimination, calibration and reclassification parameters were evaluated with the addition of eGFR to the prognostic model.

resultsAmong 1943 patients (mean age 67.3 (17.1), 50.4% women), 107 (5.5%) had died at 30 days. The 4-variable Modification of Diet in Renal Disease (eGFR

conclusionThe addition of eGFR

Indexed as

Acute Kidney InjuryAgedAged, 80 and overCohort StudiesFemaleGlomerular Filtration RateHumansMaleMiddle AgedPrognosisProspective StudiesPulmonary EmbolismRegistriesRetrospective StudiesRisk AssessmentAll-cause deathPulmonary embolismRenal dysfunctionStratification

Identifiers

PMID33563311
PMCPMC7874488
OpenAlexW3128268620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.